Why the study?
Are thrombomodulin genetic variants and soluble TM plasma levels associated with coronary artery disease risk in an Indian population?
Are thrombomodulin genetic variants and soluble TM plasma levels associated with coronary artery disease risk in an Indian population?
The TM Ala455Val substitution may serve as a genetic marker for premature coronary artery disease risk in the Indian population.
Answers are grounded in this paper and cite their sources.
TM Ala455Val may mark premature CAD risk in Indians; hypothesis-generating and requires prospective validation.
CONTEXT: Thrombomodulin (TM), a natural anticoagulant have been implicated in the pathogenesis of coronary artery disease (CAD) thus emphasizing its potential role as a biomarker. OBJECTIVES: To investigate the role of the TM genetic variants and soluble TM (sTM) plasma levels in Indian population with CAD. MATERIALS AND METHODS: This case-control study involved genotyping of the entire TM gene and sTM levels estimation in 266 subjects. RESULTS: None of the four TM genetic variants identified significantly increased CAD risk in the study population. However, further subgroup analysis revealed that in subjects ≤49 years, C1418T variant (Ala455Val substitution) was significantly associated with CAD. CONCLUSION: The increased CAD risk in subjects ≤49 years due to TM Ala455Val substitution is a promising finding. Further validation on large Indian cohorts is required in order to screen asymptomatic young subjects for CAD risk and to establish the clinical utility of Ala455Val substitution.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: